Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Mayo Clin Proc. 2018 Aug;93(8):980–990. doi: 10.1016/j.mayocp.2018.05.027

Table 2B.

Anti-HTN Drugs Prescribed in Subjects with Diagnosis of HTN Taking Two Drugs (n=145)

Drug Combination Frequencya Percentb
Beta Blocker + Diuretic 51 10.7
Ace Inhibitor + Diuretic 32 6.7
Calcium Channel Blocker + Diuretic 16 3.4
Beta Blocker + Ace Inhibitor 13 2.7
Angiotensin Receptor Blocker + Diuretic 8 1.7
Beta Blocker + Calcium Channel Blocker 8 1.7
Calcium Channel Blocker + Ace Inhibitor 7 1.5
Calcium Channel Blocker + Vasodilator 4 0.8
Diuretic + Vasodilator 2 0.4
Calcium Channel Blocker + Angiotensin Receptor Blocker 2 0.4
Ace Inhibitor + Vasodilator 1 0.2
Beta Blocker + Vasodilator 1 0.2